NCT04075968

Brief Summary

The aim of this study is to investigate the effect of cognitive rehabilitation in group with physical exercise in patients with Multiple Sclerosis. We assume that cognitive therapy is an effective treatment for multiple sclerosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 11, 2019

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 3, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2019

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

February 10, 2021

Status Verified

February 1, 2021

Enrollment Period

12 months

First QC Date

August 11, 2019

Last Update Submit

February 6, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Neuro-psychometric Test (NPT)

    It is a test that evaluates memory, working memory, planning, organization, attendance span.Evaluation is made according to the number of items filled. The higher number items filled indicates the better status

    1 hour

  • Berg Balance Scale

    It is a scale which consists of 14 items. Each item is scored on a five-point scale (0-4).The maximum score for this assessment is 56 and the minimum score for this assessment is 0. Scores below 45 indicate balance impairment. The higher point indicates the better status

    15 minutes

  • Mini Mental State Test (MMST)

    It is a test that evaluates different subset of cognitive status including attention, memory, language, orientation, visuospatial proficiency. It is scored on a scale of 0-30 with scores. Scores above 25 are interpreted as normal cognitive status.

    10-15 minutes

Secondary Outcomes (1)

  • Modified Ashworth Scale (MAS)

    3 minutes

Study Arms (2)

group 1

exercise group; 6 weeks, twice a week, 30 minutes physical group exercises and 30 minutes general cognitive function exercises will be applied as groups.

Other: Cognitive exercise

group 2

control group; patients will be given physical and cognitive home exercise program individually.

Other: Home exercise

Interventions

Cognitive exercise will be applied

group 1

Home exercise will be applied

group 2

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with definitive Multiple Sclerosis between 20-65 years, with an Mini Mental State Test score less than 24, with an Extended Disability Status Scale score less than 4, trained for at least 5 years, have not received steroid therapy in the last 1 month

You may qualify if:

  • Patients with an Mini Mental State Test score less than 24
  • Patients with an Extended Disability Status Scale score less than 4
  • Patients trained for at least 5 years
  • Patients who have not received steroid therapy in the last 1 month

You may not qualify if:

  • Patients who have not passed at least 3 months from the last Multiple Sclerosis attack
  • Patients with hearing and vision problems that may interfere with communication
  • The patients who Have other neurological and psychiatric disorder that will cause cognitive impairment
  • Patients receiving medical treatment for spasticity, tremor, bladder disorder and fatigue

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Sciences University Istanbul Physical Therapy and Rehabilitation Training and Research Hospital

Istanbul, 34500, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Arzu Esmeray

    IstanbulPMHTRH

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2019

First Posted

September 3, 2019

Study Start

December 1, 2018

Primary Completion

November 15, 2019

Study Completion

December 1, 2019

Last Updated

February 10, 2021

Record last verified: 2021-02

Locations